| Literature DB >> 24486959 |
Ana M Espinosa-Oliva1, Rocío M de Pablos1, Manuel Sarmiento1, Ruth F Villarán1, Alejandro Carrillo-Jiménez1, Marti Santiago1, José L Venero1, Antonio J Herrera1, Josefina Cano1, Alberto Machado2.
Abstract
Research indicates that inflammation and microglial activation are involved in the initiation and progression of Parkinson's disease (PD). Neuroinflammation contributes to the infiltration of peripheral immune cells and blood-brain barrier (BBB) leakage, linking peripheral and central inflammatory events in the pathogenesis of PD. Dopamine (DA) likely plays a role in this process. In the present study, the dopaminergic toxin 6-hydroxydopamine (6-OHDA) was used to damage dopaminergic neurons. Injection of 6-OHDA within the nigrostriatal pathway produced loss of astrocytes, disruption of the BBB, microglia activation and a reduction in osteopontin (OPN) immunoreactivity. Depletion of DA content by alpha-methylparatyrosine (α-MPT, a tyrosine hydroxylase inhibitor) reduced the infiltration of peripheral macrophages as well as the 6-OHDA-induced increase in microglial cells. DA could therefore be relevant in sustaining inflammation and lymphocyte recruitment induced by 6-OHDA, supporting DA implication in the degeneration of dopaminergic neurons induced by inflammatory processes.Entities:
Keywords: Dopaminergic brain structures; Inflammation; Macrophages; Monocytes infiltration; Neurodegeneration
Mesh:
Substances:
Year: 2014 PMID: 24486959 DOI: 10.1016/j.neuro.2014.01.006
Source DB: PubMed Journal: Neurotoxicology ISSN: 0161-813X Impact factor: 4.294